Novo Nordisk Aktie
47,48
EUR
-0,43
EUR
-0,89
%
46,75
EUR
-1,29
EUR
-2,68
%
Werbung
Novo Nordisk Aktie Analyse
04.08.22 | Novo Nordisk Overweight | Barclays Capital | |
03.08.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
18.07.22 | Novo Nordisk Overweight | Barclays Capital | |
14.07.22 | Novo Nordisk Outperform | Bernstein Research | |
13.07.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
24.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
21.06.22 | Novo Nordisk Buy | Deutsche Bank AG | |
Werbung
|
|||
16.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
13.06.22 | Novo Nordisk Overweight | Barclays Capital | |
08.06.22 | Novo Nordisk Buy | Deutsche Bank AG | |
07.06.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
24.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
12.05.22 | Novo Nordisk Overweight | Barclays Capital | |
11.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
05.05.22 | Novo Nordisk Outperform | Bernstein Research | |
05.05.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
03.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
29.04.22 | Novo Nordisk Outperform | Bernstein Research | |
29.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
21.04.22 | Novo Nordisk Outperform | Bernstein Research | |
12.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
01.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
16.03.22 | Novo Nordisk Buy | Deutsche Bank AG | |
04.03.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
15.02.22 | Novo Nordisk Overweight | Barclays Capital | |
03.02.22 | Novo Nordisk Outperform | Bernstein Research | |
02.02.22 | Novo Nordisk Outperform | Bernstein Research | |
02.02.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
31.01.22 | Novo Nordisk Overweight | Barclays Capital | |
26.01.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
24.01.22 | Novo Nordisk Outperform | Bernstein Research | |
04.01.22 | Novo Nordisk Outperform | Bernstein Research | |
21.12.21 | Novo Nordisk Overweight | Barclays Capital | |
07.12.21 | Novo Nordisk Buy | Deutsche Bank AG | |
29.11.21 | Novo Nordisk Buy | Deutsche Bank AG | |
26.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
26.11.21 | Novo Nordisk Outperform | Bernstein Research | |
22.11.21 | Novo Nordisk Overweight | Barclays Capital | |
18.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.21 | Novo Nordisk Overweight | Barclays Capital | |
04.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.11.21 | Novo Nordisk Outperform | Bernstein Research | |
03.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
01.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
29.10.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
Werbung
Werbung